利伐沙班在急性冠状动脉综合征中的应用研究

Application of Rivaroxaban in Acute Coronary Syndrome

目的探讨利伐沙班片在急性冠状动脉综合征中的应用研究。方法选取2016年1月至2018年1月在沈北新区中心医院内二科就诊的80例急性冠状动脉综合征患者,随机分为试验组40例,对照组40例,均采用常规治疗。试验组加利伐沙班片治疗。比较两组患者心血管事件发生率和出血发生率。结果两组患者观察指标比较,试验组各指标优于对照组,差异有统计学意义(P<0.05)。结论利伐沙班片治疗急性冠状动脉综合征疗效显著,安全性高,值得推广。

Objective To investigate the application of Rivaroxaban tablets in acute coronary syndrome. Methods From January 2016 to January 2018, 80 patients with acute coronary syndrome treated in the No.2 Department of Internal Medicine, Shenyang Shenbei New District Central Hospital were randomlydivided into 40 groups, 40 cases in the control group. The experimental group was treated with felling Shaaban. The incidence of cardiovascular events andthe incidence of bleeding were compared between the two groups. Results The observation indexes of the two groups were compared, and the indexes ofthe experimental group were better than those of the control group, the difference was statistically significant(P<0.05). Conclusion Rivaroxaban tablets iseffective and safe in the treatment of acute coronary syndromes. It is worth popularizing.